The 3 Highest-Rated Medical Stocks You Can Buy Today

In the U.S. alone, national health expenditure is expected to increase annually from 2023 and 2032, according to the Centers for Medicare & Medicaid Services. So, profit is to be had in medicine — but only if you move fast enough. A Strong Buy rating from analysts Positive revenue and net income growth in its last annual report Trades above $10 Vericel (VCEL) Vericel (NASDAQ:VCEL) specializes in severe burns and sports medicines in the United States. The company has three main products: The company previous ...